MedSchool: Ace Your OSCEsThe Medical Company
GET - On the App Store
Drug Guide


    • Mechanism of Action

    • Reversibly inhibits factor IIa (thrombin), resulting in reduced fibrin clot formation.
    • Pharmacology

    • Idarucizumab (praxbind) may be used to reverse dabigatran in life-threatening situations only.

Clinical Use

    • Indications
    • Prevention of venous thromboembolism post hip / knee surgery
    • Treatment of venous thromboembolism (DVT / PE)
    • Non-valvular atrial fibrillation (prevention of stroke)
    • Contraindications
    • Active bleeding or risk of major bleeding
    • Use of other anticoagulants
    • Mechanical heart valve
    • Severe renal impairment (eGFR
    • Adverse Effects
    • Haemorrhage
    • Oesophageal ulceration
    • Monitoring

    • A dilute thrombin time assay may be used to monitor dabigatran.
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Sign Up Now